Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


December 11-12, 2018
The Westin Washington, D.C. City Center,
Washington, D.C.

Marshal in the Next Era of US Regulatory Policy as it Intersects with Breakthrough Scientific Innovation

Connect with FDA, CMS and CDRH for Regulatory Updates, Policies and Initiatives Impacting BioPharma and Medical Devices

Save $500

Register by August 17 and save $500 off the industry rate!

Get latest information on CDER, biosimilars, and PROs directly from decision-makers

Know What's Coming Down the Pipeline

Hear directly from CDER on goals, trends, and new drug development for 2018 and beyond.

Biosimilar Development

Evaluate the economics, impact and FDA considerations in biosimilar labeling, manufacturing, and approval.

The Path Forward for PROs and Real World Evidence

Understand the evolving role of the patient voice in drug development through a panel of advocates, industry and FDA leaders.

FDA/CMS Speaker Q&A's

Sponsor the 2018 Event